Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer

<i>Background and Objectives</i>: Kidney and brain protein (KIBRA) is a protein encoded by the WW and C2 domain containing 1 (<i>WWC1</i>) gene and is involved in the Hippo signaling pathway. Recent studies have revealed the prognostic value of KIBRA expression; however, its...

Full description

Bibliographic Details
Main Authors: So-Woon Kim, Jinah Chu, Sung-Im Do, Kiyong Na
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/57/8/837
_version_ 1797523020822085632
author So-Woon Kim
Jinah Chu
Sung-Im Do
Kiyong Na
author_facet So-Woon Kim
Jinah Chu
Sung-Im Do
Kiyong Na
author_sort So-Woon Kim
collection DOAJ
description <i>Background and Objectives</i>: Kidney and brain protein (KIBRA) is a protein encoded by the WW and C2 domain containing 1 (<i>WWC1</i>) gene and is involved in the Hippo signaling pathway. Recent studies have revealed the prognostic value of KIBRA expression; however, its role in breast cancer remains unclear. The aim of this study was to examine KIBRA expression in relation to the clinical and pathological characteristics of patients with breast cancer and to disease outcomes. <i>Materials and Methods:</i> We analyzed the expression of KIBRA and its correlation with event-free survival (EFS) outcomes in resected samples from 486 patients with breast cancer. <i>Results:</i> KIBRA expression was significantly different among the molecular subgroups (low KIBRA expression: luminal A, 46.7% versus 50.0%, <i>p</i> = 0.641; luminal B, 32.7% versus 71.7%, <i>p</i> < 0.001; human epidermal growth factor receptor 2 (HER2)-enriched, 64.9% versus 45.5%. <i>p</i> = 0.001; triple-negative, 73.6% versus 43.8%, <i>p</i> < 0.001). Low KIBRA expression was also associated with high nuclear grade (60.4% versus 37.8%, <i>p</i> < 0.001), high histologic grade (58.7% versus 37.0%, <i>p</i> < 0.001), and estrogen receptor (ER) negativity (54.2% versus 23.6%, <i>p</i> < 0.001). Low KIBRA expression was significantly associated with poor EFS (<i>p</i> = 0.041; hazard ratio (HR) 1.658; 95% confidence interval (CI), 1.015–2.709). Low KIBRA expression was an independent indicator of poor prognosis (<i>p</i> = 0.001; HR = 3.952; 95% CI = 1.542–10.133) in triple-negative breast cancer (TNBC). <i>Conclusion:</i> Low KIBRA expression was associated with higher histological grade, ER negativity and poor EFS of breast cancer. In particular, our data highlight KIBRA expression status as a potential prognostic marker for TNBC.
first_indexed 2024-03-10T08:37:31Z
format Article
id doaj.art-d4b6b42be92c4cfb9361ca6095b68b38
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-10T08:37:31Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-d4b6b42be92c4cfb9361ca6095b68b382023-11-22T08:36:51ZengMDPI AGMedicina1010-660X1648-91442021-08-0157883710.3390/medicina57080837Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast CancerSo-Woon Kim0Jinah Chu1Sung-Im Do2Kiyong Na3Department of Pathology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, KoreaDepartment of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 03181, KoreaDepartment of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 03181, KoreaDepartment of Pathology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea<i>Background and Objectives</i>: Kidney and brain protein (KIBRA) is a protein encoded by the WW and C2 domain containing 1 (<i>WWC1</i>) gene and is involved in the Hippo signaling pathway. Recent studies have revealed the prognostic value of KIBRA expression; however, its role in breast cancer remains unclear. The aim of this study was to examine KIBRA expression in relation to the clinical and pathological characteristics of patients with breast cancer and to disease outcomes. <i>Materials and Methods:</i> We analyzed the expression of KIBRA and its correlation with event-free survival (EFS) outcomes in resected samples from 486 patients with breast cancer. <i>Results:</i> KIBRA expression was significantly different among the molecular subgroups (low KIBRA expression: luminal A, 46.7% versus 50.0%, <i>p</i> = 0.641; luminal B, 32.7% versus 71.7%, <i>p</i> < 0.001; human epidermal growth factor receptor 2 (HER2)-enriched, 64.9% versus 45.5%. <i>p</i> = 0.001; triple-negative, 73.6% versus 43.8%, <i>p</i> < 0.001). Low KIBRA expression was also associated with high nuclear grade (60.4% versus 37.8%, <i>p</i> < 0.001), high histologic grade (58.7% versus 37.0%, <i>p</i> < 0.001), and estrogen receptor (ER) negativity (54.2% versus 23.6%, <i>p</i> < 0.001). Low KIBRA expression was significantly associated with poor EFS (<i>p</i> = 0.041; hazard ratio (HR) 1.658; 95% confidence interval (CI), 1.015–2.709). Low KIBRA expression was an independent indicator of poor prognosis (<i>p</i> = 0.001; HR = 3.952; 95% CI = 1.542–10.133) in triple-negative breast cancer (TNBC). <i>Conclusion:</i> Low KIBRA expression was associated with higher histological grade, ER negativity and poor EFS of breast cancer. In particular, our data highlight KIBRA expression status as a potential prognostic marker for TNBC.https://www.mdpi.com/1648-9144/57/8/837KIBRAbreast cancertriple-negative breast cancerHippo pathway
spellingShingle So-Woon Kim
Jinah Chu
Sung-Im Do
Kiyong Na
Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer
Medicina
KIBRA
breast cancer
triple-negative breast cancer
Hippo pathway
title Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer
title_full Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer
title_fullStr Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer
title_full_unstemmed Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer
title_short Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer
title_sort low kibra expression is associated with poor prognosis in patients with triple negative breast cancer
topic KIBRA
breast cancer
triple-negative breast cancer
Hippo pathway
url https://www.mdpi.com/1648-9144/57/8/837
work_keys_str_mv AT sowoonkim lowkibraexpressionisassociatedwithpoorprognosisinpatientswithtriplenegativebreastcancer
AT jinahchu lowkibraexpressionisassociatedwithpoorprognosisinpatientswithtriplenegativebreastcancer
AT sungimdo lowkibraexpressionisassociatedwithpoorprognosisinpatientswithtriplenegativebreastcancer
AT kiyongna lowkibraexpressionisassociatedwithpoorprognosisinpatientswithtriplenegativebreastcancer